NCT03203785

Brief Summary

The study is a randomized, double-blinded, placebo-controlled trial that will include the participation of 14 Jiu-Jitsu athletes between 18 and 33 years. The aim of the study is to evaluate the effects of carbohydrate consumption on fatigue and exercise-induced muscle damage in Jiu-Jitsu athletes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

June 26, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

6 months

First QC Date

June 26, 2017

Last Update Submit

January 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in upper limbs strength

    Kimono Grip Strength Test

    Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise

Secondary Outcomes (6)

  • change in lower limbs power

    Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise

  • change in hand grip strength

    Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise

  • change in creatine kinase

    Pre-exercise; immediatly post-exercise; 24hour and 48hour after exercise

  • change in glucose

    Pre-exercise; at 2 intervals during exercise; immediatly post-exercise

  • change in lactate

    At 2 intervals during exercise; immediatly post-exercise

  • +1 more secondary outcomes

Study Arms (2)

Carbohydrate

EXPERIMENTAL

30g of carbohydrate (maltodextrin) diluted in 300ml of water. Athletes will drink 100ml before and 100ml in the first and second interval between exercise.

Dietary Supplement: Carbohydrate (maltodextrin)

Placebo

PLACEBO COMPARATOR

300 ml of a non-caloric drink. Athletes will drink 100ml before and 100ml in the first and second interval between exercise.

Other: Placebo

Interventions

Carbohydrate (maltodextrin)DIETARY_SUPPLEMENT

maltodextrin flavored

Carbohydrate
PlaceboOTHER

non-caloric drink

Placebo

Eligibility Criteria

Age18 Years - 33 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Compete in the categories of weight between 70kg and 88,3kg (weight classification from light to medium heavy, belonging to the bands purple to brown).
  • Age between 18 and 33 years.
  • Be training at least three times a week, minimum of 1,5 hours per day, for at least 3 consecutive months.
  • Have not used anabolic steroids in the last 6 months during the study period.
  • Do not use any type of dietary supplement in the last 3 months.
  • Self-declared healthy individuals.

You may not qualify if:

  • Recent muscle injury (within the last 3 months) that compromises and / or impedes the performance of the exercise requested in the study.
  • Be in a time of rapid weight loss (pre-competition).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriella B. Möller

Pôrto Alegre, Rio Grande do Sul, 90050170, Brazil

Location

MeSH Terms

Conditions

Fatigue

Interventions

Carbohydratesmaltodextrin

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Claudia D Schneider, PhD

    Federal University of Health Science of Porto Alegre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 26, 2017

First Posted

June 29, 2017

Study Start

June 26, 2017

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

January 16, 2019

Record last verified: 2019-01

Locations